NextGen Sciences, Berg Diagnostics
Neal Siegel, Glenn Barney, Hiroshi Saito, Jay Moyes, Michael Marletta, Richard Lerner
In about a month, the company plans to offer four assays targeted to neurodegenerative disease and heart disease, its CEO said.
The assays will be used by the drug company for preclinical and clinical studies.
Thermo Fisher's BRIMS Center is collaborating with NextGen Sciences to improve that company's suite of biomarker services.
The sale, for undisclosed cash and royalties, completes NextGen's realignment toward biomarker services.
Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing.
Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.
Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports.
In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.